eicosapentaenoic acid ethyl ester has been researched along with pravastatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamoto, T; Kawano, H; Mizuguchi, K; Mochizuki, H; Yamashita, M; Yano, T | 1 |
| Ito, T; Kushihata, S; Masaki, T; Nishida, Y; Oda, H; Taniguchi, Y; Yamakido, M; Yorioka, N | 1 |
| Kakinuma, C; Naba, H; Ogihara, T; Ohnishi, S | 1 |
3 other study(ies) available for eicosapentaenoic acid ethyl ester and pravastatin
| Article | Year |
|---|---|
Effects of ethyl-all-cis-5,8,11,14,17-icosapentaenoate (EPA-E), pravastatin and their combination on serum lipids and intimal thickening of cuff-sheathed carotid artery in rabbits.
Topics: Animals; Anticholesteremic Agents; Carotid Arteries; Cholesterol; Drug Interactions; Eicosapentaenoic Acid; Lipids; Male; Phospholipids; Pravastatin; Rabbits; Triglycerides | 1997 |
Lipid-lowering therapy and coagulation/fibrinolysis parameters in patients on peritoneal dialysis.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Coagulation Factors; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Fibrinolysis; Humans; Hyperlipidemias; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Platelet Aggregation Inhibitors; Pravastatin; Statistics, Nonparametric; Treatment Outcome | 2000 |
Improving effect of ethyl eicosapentanoate on statin-induced rhabdomyolysis in Eisai hyperbilirubinemic rats.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Eicosapentaenoic Acid; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperbilirubinemia; Muscle, Skeletal; Platelet Aggregation Inhibitors; Pravastatin; Rats; Rhabdomyolysis; Severity of Illness Index; Treatment Outcome | 2006 |